Literature DB >> 19857043

UGT genomic diversity: beyond gene duplication.

Chantal Guillemette1, Eric Lévesque, Mario Harvey, Judith Bellemare, Vincent Menard.   

Abstract

The human uridine diphospho (UDP)-glucuronosyltransferase (UGT) superfamily comprises enzymes responsible for a major biotransformation phase II pathway: the glucuronidation process. The UGT enzymes are located in the endoplasmic reticulum of almost all tissues, where they catalyze the inactivation of several endogenous and exogenous molecules, including bilirubin, sex steroids, numerous prescribed drugs, and environmental toxins. This metabolic pathway is particularly variable. The influence of inheritable polymorphisms in human UGT-encoding genes has been extensively documented and was shown to be responsible for a fraction of the observed phenotypic variability. Other key genomic processes are likely underlying this diversity; these include copy-number variations, epigenetic factors, and newly discovered splicing mechanisms. This review will discuss novel molecular aspects that may be determinant to UGT phenotypes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19857043     DOI: 10.3109/03602530903210682

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  36 in total

1.  Multiplexed Targeted Quantitative Proteomics Predicts Hepatic Glucuronidation Potential.

Authors:  Guillaume Margaillan; Michèle Rouleau; Kathrin Klein; John K Fallon; Patrick Caron; Lyne Villeneuve; Philip C Smith; Ulrich M Zanger; Chantal Guillemette
Journal:  Drug Metab Dispos       Date:  2015-06-15       Impact factor: 3.922

2.  Hepatic expression of transcription factors affecting developmental regulation of UGT1A1 in the Han Chinese population.

Authors:  Ya-Li Nie; Hang He; Jiang-Feng Li; Xiang-Guang Meng; Liang Yan; Pei Wang; Shu-Jie Wang; Hong-Zheng Bi; Li-Rong Zhang; Quan-Cheng Kan
Journal:  Eur J Clin Pharmacol       Date:  2016-10-05       Impact factor: 2.953

3.  Enzymatic analysis of glucuronidation of synthetic cannabinoid 1-naphthyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate (FDU-PB-22).

Authors:  Sabrina Jones; Azure L Yarbrough; Amal Shoeib; John M Bush; William E Fantegrossi; Paul L Prather; Anna Radominska-Pandya; Ryoichi Fujiwara
Journal:  Xenobiotica       Date:  2019-03-20       Impact factor: 1.908

4.  Regulation of UGT2B Expression and Activity by miR-216b-5p in Liver Cancer Cell Lines.

Authors:  Douglas F Dluzen; Aimee K Sutliff; Gang Chen; Christy J W Watson; Faoud T Ishmael; Philip Lazarus
Journal:  J Pharmacol Exp Ther       Date:  2016-07-29       Impact factor: 4.030

Review 5.  Alternative Splicing: Expanding Diversity in Major ABC and SLC Drug Transporters.

Authors:  Ji Eun Park; Gongmi Ryoo; Wooin Lee
Journal:  AAPS J       Date:  2017-10-02       Impact factor: 4.009

6.  Post-transcriptional Regulation of UGT2B10 Hepatic Expression and Activity by Alternative Splicing.

Authors:  Adrien Labriet; Eric P Allain; Michèle Rouleau; Yannick Audet-Delage; Lyne Villeneuve; Chantal Guillemette
Journal:  Drug Metab Dispos       Date:  2018-02-09       Impact factor: 3.922

7.  Enantiomer selective glucuronidation of the non-steroidal pure anti-androgen bicalutamide by human liver and kidney: role of the human UDP-glucuronosyltransferase (UGT)1A9 enzyme.

Authors:  Laurent Grosse; Anne-Sophie Campeau; Sarah Caron; Frédéric-Alexandre Morin; Kim Meunier; Jocelyn Trottier; Patrick Caron; Mélanie Verreault; Olivier Barbier
Journal:  Basic Clin Pharmacol Toxicol       Date:  2013-05-20       Impact factor: 4.080

8.  Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density.

Authors:  Vilde D Haakensen; Margarethe Biong; Ole Christian Lingjærde; Marit Muri Holmen; Jan Ole Frantzen; Ying Chen; Dina Navjord; Linda Romundstad; Torben Lüders; Ida K Bukholm; Hiroko K Solvang; Vessela N Kristensen; Giske Ursin; Anne-Lise Børresen-Dale; Aslaug Helland
Journal:  Breast Cancer Res       Date:  2010-08-27       Impact factor: 6.466

9.  Nicotine regulates the expression of UDP-glucuronosyltransferase (UGT) in humanized UGT1 mouse brain.

Authors:  Masaya Sakamoto; Tomoo Itoh; Robert H Tukey; Ryoichi Fujiwara
Journal:  Drug Metab Pharmacokinet       Date:  2015-05-07       Impact factor: 3.614

10.  Identification and validation of genes with expression patterns inverse to multiple metastasis suppressor genes in breast cancer cell lines.

Authors:  Natascia Marino; Joshua W Collins; Changyu Shen; Natasha J Caplen; Anand S Merchant; Yesim Gökmen-Polar; Chirayu P Goswami; Takashi Hoshino; Yongzhen Qian; George W Sledge; Patricia S Steeg
Journal:  Clin Exp Metastasis       Date:  2014-08-03       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.